| Previous Close | 76.91 |
| Open | 76.96 |
| Bid | 73.00 x 100 |
| Ask | 78.73 x 200 |
| Day's Range | 76.52 - 77.35 |
| 52 Week Range | 56.70 - 81.06 |
| Volume | 659,521 |
| Avg. Volume | 652,171 |
| Market Cap | 3.89B |
| Beta | 1.13 |
| PE Ratio (TTM) | 80.57 |
| EPS (TTM) | 0.95 |
| Earnings Date | Jul 24, 2017 - Jul 28, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 82.57 |
Zacks•13 days agoNuVasive (NUVA) at 52-Week High: What's Driving the Stock?
Share price of NuVasive, Inc. (NUVA) scaled a new 52-week high of $81.06 on Jun 9, eventually closing a bit lower at $79.13.
- PR Newswire•20 days ago
NuVasive Magnetic, Non-Invasive Platforms Featured In The Journal Of Orthopaedic Trauma Supplement
SAN DIEGO, June 5, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, ...
- PR Newswire•24 days ago
NuVasive Appoints Skip Kiil As Executive Vice President, International
SAN DIEGO, June 1, 2017 /PRNewswire/ -- NuVasive, Inc. (NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced Skip Kiil is joining the Company as executive vice president, International. In this role, Mr. Kiil will oversee the Company's international operations, reporting to NuVasive's chairman and chief executive officer, Gregory T. Lucier, and serving on the Company's executive leadership team.